Analyst Ratings for Aquestive Therapeutics (AQST)
AQST Rating Summary
AQST Price Target Summary
- Highest: $15.00 (Cantor Fitzgerald)
- Lowest: $6.00 (Lake Street )
- Average: $9.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.50 (+101.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$9.50 (+101.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2026 | Oppenheimer | Mazahir Alimohamed | New Coverage | Outperform (N/A) |
8.00 (N/A) |
4.07 (4.71) |
15.72% | Details |
| 12/17/2024 | Cantor Fitzgerald » Updated 8/19/2025 |
Kristen Kluska | New Coverage | Overweight (N/A) |
15.00 (N/A) |
3.60 (4.71) |
30.83% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
